Z-Asp-CH2-DCB
CAS No. 153088-73-4
Z-Asp-CH2-DCB( —— )
Catalog No. M26516 CAS No. 153088-73-4
Z-Asp-CH2-DCB is an irreversible inhibitor of broad spectrum caspase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 71 | Get Quote |
|
| 5MG | 138 | Get Quote |
|
| 10MG | 205 | Get Quote |
|
| 25MG | 347 | Get Quote |
|
| 50MG | 510 | Get Quote |
|
| 100MG | 712 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZ-Asp-CH2-DCB
-
NoteResearch use only, not for human use.
-
Brief DescriptionZ-Asp-CH2-DCB is an irreversible inhibitor of broad spectrum caspase.
-
DescriptionZ-Asp-CH2-DCB is an irreversible inhibitor of broad spectrum caspase.(In Vitro):Z-Asp-CH2-DCB (10-100 μM) dose-dependently blocks the production of IL-1β, TNF-α, IL-6, and IFN-γ in SEB-stimulated (200 ng) PBMC. Z-Asp-CH2-DCB suppresses the production of the chemokines MCP-1, MIP-1α, and MIP-1β. Z-Asp-CH2-DCB inhibits TSST-1-activated PBMC and reduces IL-1β, IL-6, TNF-α, IFN-γ, MCP-1, MIP-1α, and MIP-1β to 10, 36, 25, 10, 11, 25, and 30%, respectively.(In Vivo):SU5416-induced septal cell apoptosis prevented byZ-Asp-CH2-DCB (1 mg; i.p.; every day for 3 weeks).
-
In VitroZ-Asp-CH2-DCB (10-100 μM) blocks the production of IL-1β, TNF-α, IL-6, and IFN-γ in SEB-stimulated (200 ng; 16 hours) PBMC in a dose-dependent manner. The production of the chemokines MCP-1, MIP-1α, and MIP-1β was also suppresses. The inhibitory effect of Z-Asp-CH2-DCB on TSST-1-activated PBMC is similar, reducing IL-1β, IL-6, TNF-α, IFN-γ, MCP-1, MIP-1α, and MIP-1β to 10, 36, 25, 10, 11, 25, and 30%, respectively, of levels in untreated cells.Z-Asp-CH2-DCB (10-100 μM; 48 hours) inhibits T-cell proliferation in PBMC stimulated with 200 ng of SEB/ml .Cell Viability Assay Cell Line:Human peripheral blood mononuclear cells Concentration:10, 50, 100 μM Incubation Time:48 hours Result:Inhibited T-cell proliferation in PBMC stimulated with SEB.
-
In VivoZ-Asp-CH2-DCB (1 mg; i.p.; every day for 3 weeks) prevents SU5416-induced septal cell apoptosis. Animal Model:Male Sprague-Dawley rats (SU5416+ Z-Asp-CH2-DCB group)Dosage:1 mg Administration:Intraperitoneal injection; every day for 3 weeks Result:The caspase 3-like activity in SU5416-treated rat lungs is significantly higher, whereas lungs from rats treated with SU5416+Z-Asp-CH2-DCB showed no increase in apoptotic activity.
-
Synonyms——
-
PathwayNF-κB
-
TargetNOD
-
RecptorAMPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number153088-73-4
-
Formula Weight454.26
-
Molecular FormulaC20H17Cl2NO7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (220.14 mM)
-
SMILESOC(=O)C[C@H](NC(=O)OCc1ccccc1)C(=O)COC(=O)c1c(Cl)cccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Savall BM, et al. Discovery of Imidazo[1,2-a]pyrazines and Pyrazolo[1,5-c]pyrimidines as TARP γ-8 Selective AMPAR Negative Modulators. ACS Med Chem Lett. 2018 Dec 26;10(3):267-272.
molnova catalog
related products
-
MCC950
MCC950 (CP-456773) is a potent, selective, small-molecule inhibitor of NLRP3 inflammasome with IC50 of 7.5 and 8.1 nM in BMDM and HMDM, respectively.
-
Asymmetric dimethyla...
Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).
-
NP3-146
NP3-146 (NLRP3-IN-5) is an inflammasome NLRP3 inhibitor with potential anti-inflammatory activity for the study of autoimmune diseases.
Cart
sales@molnova.com